PURCHASE, N.Y., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) announced that Willem de Haan ...
BrainScope demonstrates ability of its EEG-based biomarker to identify individuals at risk of cognitive decline within 5 to 7 years before diagnosis.
Morning Overview on MSN
Scientists finally decode the wild brain waves unleashed by ayahuasca
A growing body of brain-imaging research has mapped, with increasing precision, how the Amazonian psychedelic brew ayahuasca ...
Patients with brain injury who are unresponsive to commands may perform cognitive tasks that are detected on functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). This ...
– Independent prospective analysis validates theta-band inter-trial coherence (ITC) as an important, objective measure to distinguish patients with schizophrenia from healthy individuals – – A ...
Li and colleagues developed a deep-learning model to analyze EEG recordings and detect event-level EEG spikes. 2. The model achieved high accuracy and a low false-positive rate, with only 32% of human ...
Cognito Therapeutics Announces Presentation of New CSF Proteomic and EEG Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025 Cognito Therapeutics, a clinical-stage medical device company ...
Electroencephalography (EEG) may offer a more accessible alternative to functional magnetic resonance imaging (fMRI) for guiding transcranial direct current stimulation (tDCS) when treating aphasia.
Using portable EEGs, researchers found that when groups of people watch the same health promotion videos, their brain activity syncs up, indicating that the message has gone beyond being seen and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results